A phase I trial to compare the safety and immunogenicity of candidate TB vaccine MVA85A administered by the aerosol inhaled route and the intradermal route in healthy BCG vaccinated adult subjects.
Phase of Trial: Phase I
Latest Information Update: 01 Oct 2014
At a glance
- Drugs MVA 85A (Primary) ; MVA 85A (Primary)
- Indications Tuberculosis
- Focus Adverse reactions; Pharmacodynamics
- 01 Apr 2013 Status changed from active, no longer recruiting to completed as reported by ClinicalTrials.gov.
- 18 Dec 2012 Status changed from recruiting to active, no longer recruiting as reported by United Kingdom Clinical Research Network.
- 15 Nov 2012 Accrual to date is 100% according to United Kingdom Clinical Research Network.